CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NeoVanc project focuses on optimizing vancomycin treatment for neonatal Late Onset Sepsis by developing a new formulation and determining effective dosage levels. It aims to establish a standardized dosing regimen based on pre-clinical studies and conduct a clinical trial to evaluate treatment efficacy and safety i…
Vancomycin is the critically important antibiotic to treat neonatal Late Onset Sepsis (LOS) due to Gram positive bacteria in neonates, including Coagulase Negative Staphylococci (CoNS) and Staphylococcus aureus.
These organisms also create biofilms which are extremely resistant to antibiotics.
The increased incidence of LOS due to bacteria such as CoNS and MRSA in NICUs has led to a marked increased use of vancomycin, which is now the third commonest antibiotic used in European NICUs.
However, a…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Estonia, Tartu
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE
Italy, Bari
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
